Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Anderson

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 20, 2014
The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathwaysTatyana Isayeva, Jie Xu, Camille Ragin, et al.
ACS Nano|October 22, 2024
Glycopolymeric Nanoparticles Enrich Less Immunogenic Protein Coronas, Reduce Mononuclear Phagocyte Clearance, and Improve Tumor Delivery Compared to PEGylated NanoparticlesKenneth Hulugalla, Oluwaseyi Shofolawe-Bakare, Veeresh B Toragall, et al.
Oncotarget|August 30, 2023
Analytic validation of NeXT Dx™, a comprehensive genomic profiling assayJuan-Sebastian Saldivar, Jason Harris, Erin Ayash, et al.
Oncotarget|March 14, 2024
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assayJosette Northcott, Gabor Bartha, Jason Harris, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 20, 2014
The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathwaysTatyana Isayeva, Jie Xu, Camille Ragin, et al.
ACS Nano|October 22, 2024
Glycopolymeric Nanoparticles Enrich Less Immunogenic Protein Coronas, Reduce Mononuclear Phagocyte Clearance, and Improve Tumor Delivery Compared to PEGylated NanoparticlesKenneth Hulugalla, Oluwaseyi Shofolawe-Bakare, Veeresh B Toragall, et al.
Oncotarget|August 30, 2023
Analytic validation of NeXT Dx™, a comprehensive genomic profiling assayJuan-Sebastian Saldivar, Jason Harris, Erin Ayash, et al.
Oncotarget|March 14, 2024
Analytical validation of NeXT Personal®, an ultra-sensitive personalized circulating tumor DNA assayJosette Northcott, Gabor Bartha, Jason Harris, et al.
Pageof 3